The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus.

MLA

Hong S, et al. “The PPARγ Agonist Rosiglitazone Prevents Cognitive Impairment by Inhibiting Astrocyte Activation and Oxidative Stress Following Pilocarpine-Induced Status Epilepticus.” Neurological Sciences, vol. 33, no. 3, June 2012, pp. 559–66. EBSCOhost, https://doi.org/10.1007/s10072-011-0774-2.

APA

Hong S, Xin Y, Haiqin W, Guilian Z, Ru Z, Shuqin Z, Huqing W, Li Y, Yun D, Hong, S., Xin, Y., HaiQin, W., GuiLian, Z., Ru, Z., ShuQin, Z., HuQing, W., Li, Y., & Yun, D. (2012). The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus. Neurological Sciences, 33(3), 559–566. https://doi.org/10.1007/s10072-011-0774-2

Chicago

Hong S, Xin Y, Haiqin W, Guilian Z, Ru Z, Shuqin Z, Huqing W, et al. 2012. “The PPARγ Agonist Rosiglitazone Prevents Cognitive Impairment by Inhibiting Astrocyte Activation and Oxidative Stress Following Pilocarpine-Induced Status Epilepticus.” Neurological Sciences 33 (3): 559–66. doi:10.1007/s10072-011-0774-2.